🔎 Trials Near Me

ホーム › COPD › テキサス › Houston

Houston、TXにおけるCOPDの臨床試験

Houstonとその周辺地域(約30マイル以内)の拠点で、COPDに関する15件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

被験者募集中第3相
  • Se Houston- Site Number : 8400120, Houston
  • Aavon Clinical Trials, Llc- Site Number : 8400166, Houston
40歳〜80歳 · 全性別 · 2026/10/01更新 · NCT07190222

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

被験者募集中第2相
  • Baylor College of Medicine Medical Center, Houston
40歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

被験者募集中第3相
  • Trio Clinical Trials- Site Number : 8400106, Houston
  • HDH Research- Site Number : 8400104, Houston
  • Baylor College of Medicine- Site Number : 8400076, Houston
  • 他2件
40歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

被験者募集中第2相
  • Research Site, Houston
40歳以上 · 全性別 · 2026/09/09更新 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

被験者募集中第2相
  • Baylor College of Medicine, Houston
40歳以上 · 全性別 · 2026/09/04更新 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

被験者募集中第3相
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

被験者募集中第3相
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Humble · 17マイル先
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

被験者募集中第2/3相
  • Greater Heights & Memorial Pulmonary and Sleep, Houston
  • Houston Pulmonary Sleep and Allergy Associates, Houston
35歳〜80歳 · 全性別 · 2026/08/31更新 · NCT07363694

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

被験者募集中第3相
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
40歳〜80歳 · 全性別 · 2026/08/26更新 · NCT06283966

STRIVE Post-Market Registry Study

被験者募集中観察研究
  • University of Texas Health Science Center at Houston, Houston
18歳以上 · 全性別 · 2026/08/03更新 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

被験者募集中第3相
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
40歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07177339

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

被験者募集中
  • Houston Methodist/Primary Critical Care, Houston
40歳〜84歳 · 全性別 · 2026/04/24更新 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

被験者募集中第3相
  • GSK Investigational Site, Houston
40歳〜80歳 · 全性別 · 2026/04/09更新 · NCT06961214

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

被験者募集中観察研究
  • Horizon Clinical Research Group, Houston
50歳以上 · 全性別 · 2025/08/05更新 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

被験者募集中
  • Respire Research Institute, Houston
30歳以上 · 全性別 · 2025/02/06更新 · NCT05204888

他の都市におけるCOPDの試験

Houstonにおける他の研究

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。